Innovative Financing for Health: the GAVI Alliance 21 st century model

Transcription

1 Innovative Financing for Health: the GAVI Alliance 21 st century model Marie-Ange Saraka-Yao GAVI Alliance Geneva / Switzerland msarakayao@gavialliance.org

2 The GAVI Alliance: an innovative partnership

3 Mission and strategic goals To save children s lives and protect people s health by increasing access to immunisation in poor countries 1 2 The vaccine goal Accelerate the uptake and use of underused and new vaccines 3 4 The financing goal Increase the predictability of global financing and improve the sustainability of national financing for immunisation The health systems goal Contribute to strengthening the capacity of integrated health systems to deliver immunisation The market shaping goal Shape vaccine markets to ensure adequate supply of appropriate, quality vaccines at low and sustainable prices

4 GAVI making a difference Catalysing accelerated uptake of vaccines Contributed to preventing more than 5.5 million future deaths 370 million additional children immunised Supporting increasing country demand Rising demand for new vaccines US$ 7.5 billion committed to countries Introducing innovative finance mechanisms IFFIm raised US$ 3.7 billion on capital markets AMC accelerates access to pneumococcal vaccines GAVI Matching Fund engaging the private sector Shaping markets for vaccines More manufacturers producing more appropriate vaccines Increased capacity secures supply, decreases prices

5 GAVI supports the world s poorest countries Type and value of support, Source: GAVI Alliance, 2012

6 A strong platform Source: WHO/UNICEF vaccine coverage estimates (July 2012) Country income categories (World Bank) as of July 2012 (2011 GNI per capita)

7 Driving equity in vaccine access Hepatitis B Hib Source: WHO, Vaccine introduction database. Country income categories (World Bank) as of July 2012 (2011 GNI per capita)

8 US$ 7.5 billion committed to As of 31 December 2012 countries Source: GAVI Alliance data as of 31 December Note: These commitments are from inception until 31 December 2012.

9 International Finance Facility for Immunisation (IFFIm) Supports GAVI by accelerating availability and predictability of funds for immunisation Uses US$ 6.3 billion in long-term donor pledges to back the issuance of bonds (AAA/Aaa/AA+) on the capital markets Raised US$ 3.7 billion since 2006 Provides long-term predictable funding for immunisation This helps multi-year planning, market shaping and rapid roll-out of new vaccines

10 IFFIm frontloading Provides GAVI with an overdraft or bridging facility Source: World Bank, July 2012

11 IFFIm s donors Donors Length of commitment Grant (US$ equivalent) United Kingdom 20 years US$ 2,980 million France 20 years US$ 1,719 million Italy 20 years US$ 635 million Norway 5 years US$ 264 million** Australia 20 years US$ 256 million Approximately US$ 6.3 billion* Spain 20 years US$ 240 million The Netherlands 7 years US$ 114 million Sweden 15 years US$ 38 million South Africa 20 years US$ 20 million Brazil*** 20 years US$ 20 million * US$6.3 billion is the US$ equivalent of the pledges using the prevailing exchange rates around the time of signing of the grant agreements. ** Norway pledged in two different currencies US$ and NOK. Total in US$ eq. for original and increase is US$ 265,100,000. *** Brazil s grant agreement is in process but has not yet been signed.

12 Pentavalent vaccine Approved for pentavalent vaccine support Source: GAVI Alliance data as of the end of March 2013

13 Advance Market Commitment (AMC) Accelerates the manufacture and delivery of vaccines: Donors commit funds for new vaccines at preagreed price Manufacturers get incentive to invest in R&D for new vaccines Vaccines must meet stringent criteria and be requested by developing countries Manufacturers legally commit to supplying vaccines at lower price long term Long-term price is paid by beneficiary countries and GAVI

14 AMC commitments: US$ 1.5 billion AMC commitments US$ millions Italy 635 United Kingdom 485 Canada 200 Russian Federation 80 Norway 50 Bill & Melinda Gates Foundation 50 Total 1,500 Source: GAVI Alliance, 2010

15 Driving equity in vaccine access Pneumococcal *Planned 2012 introductions as of July 2012 Source: WHO, Vaccine introduction database. Country income categories (World Bank) as of July 2012 (2011 GNI per capita).

16 Market shaping objectives Basic facts about GAVI DATE

17 Increased competition reduces vaccine price Price decline of pentavalent vaccine and number of manufacturers Source: UNICEF Supply Division, 2013

18 Source: UNICEF Supply Division; CDC Tiered pricing

19 Vaccine supply 2001 Vaccine supply: 5 suppliers from 5 countries Source: UNICEF Supply Division

20 Vaccine supply 2012 Vaccine supply: 10 suppliers from 8 countries Source: UNICEF Supply Division

21 Total projected number of children immunised by the end of 2012 (increase relative to the end of 2011) Sources: WHO-UNICEF coverage estimates for , as of July Coverage projections for 2012, as of September World Population Prospects, the 2010 revision. New York, United Nations, 2010; (surviving infants).

22 Number of children immunised with pneumococcal and rotavirus vaccines with GAVI support Sources: WHO-UNICEF coverage estimates for , as of July Coverage projections for 2012, as of September World Population Prospects, the 2010 revision. New York, United Nations, 2010; (surviving infants)

23 Vaccine introductions in : pentavalent, pneumococcal, rotavirus Number of newborns (millions) Sources: UN DESA, Population Division, 2011: World population prospects,

24 GAVI s co-financing policy: country ownership and steps to sustainability Country groupings: Low-income countries (<US$ 1,005 per capita GNI) pay US$ 0.20 per dose Intermediate countries (US$ 1,005 US$ 1,520) increase copayments by 15% per year Graduating countries (>US$ 1,520) increase payments steadily to reach sustainability after five years

25 How the co-financing policy works Source: GAVI Alliance data 2012

26 Co-financing: countries fulfilling commitments Source: GAVI Alliance data as of 13 March 2013

27 Australia Multilateral Aid March, 2012 Assessment

28 Thank you GAVI/2011/Ed Harris

29